QA: Nanoviricides INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2023_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 14,416,380
1 IntangibleAssetsNetIncludingGoodwill 341,848
2 PropertyPlantAndEquipmentNet 8,694,194
3 remainder_Assets 42,440
4 LiabilitiesCurrent 412,837
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,360,091
9 ResearchAndDevelopmentExpense 5,829,847
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -24,902
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,494,862
1 Liabilities 412,837
2 Expenses 8,189,938
3 Revenues 0
4 StockholdersEquity 23,082,025
5 NetIncome -8,214,840
6 ComprehensiveNetIncome -8,214,840
7 BaseVar 16,061,270
8 EconomicCapitalRatiobeforeLimitedLiability 3.52
9 EconomicCapitalRatio 4.05

Edgar->Model Mapping

Feature Distribution

Change over Time